Literature DB >> 21605031

α-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins.

Bruno Vincent1, Frederic Checler.   

Abstract

Proteases regulate numerous physiological functions in all living organisms. Because of their contribution to βAPP processing, α-, β- and γ-secretases have focused particular attention of researchers in the field of Alzheimer's disease (AD) during the past 20 years. Whereas the β-secretase BACE1 and the heterotetrameric presenilin-dependent γ- secretase complex were identified between 1995 and 2002, α-secretase activity was attributed to previously described ADAM10 and ADAM17, two members of the type I integral membrane protein family called ADAMs (A Disintegrin And Metalloprotease). ADAM10 and/or ADAM17 target numerous substrates through various modes of action. This review focuses on the complex physiology of these α-secretases and will document their contribution to cancers, diabetes, rheumatoid arthritis, and prion diseases besides their well characterized role in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21605031     DOI: 10.2174/156720512799361646

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  16 in total

1.  Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1).

Authors:  Frédéric Checler
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

2.  Alzheimer's and prion diseases: PDK1 at the crossroads.

Authors:  Frédéric Checler
Journal:  Nat Med       Date:  2013-09       Impact factor: 53.440

Review 3.  Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Santiago Rivera; Laura García-González; Michel Khrestchatisky; Kévin Baranger
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

4.  Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.

Authors:  Robert J Baranello; Krishna L Bharani; Vasudevaraju Padmaraju; Nipun Chopra; Debomoy K Lahiri; Nigel H Greig; Miguel A Pappolla; Kumar Sambamurti
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 5.  The Roles of the Stem Cell-Controlling Sox2 Transcription Factor: from Neuroectoderm Development to Alzheimer's Disease?

Authors:  Golmaryam Sarlak; Bruno Vincent
Journal:  Mol Neurobiol       Date:  2015-02-18       Impact factor: 5.590

6.  MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.

Authors:  Bing-Lin Zhu; Yan Long; Wei Luo; Zhen Yan; Yu-Jie Lai; Li-Ge Zhao; Wei-Hui Zhou; Yan-Jiang Wang; Lin-Lin Shen; Lu Liu; Xiao-Juan Deng; Xue-Feng Wang; Fei Sun; Guo-Jun Chen
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

7.  Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain.

Authors:  Francisco Gil-Bea; Susanne Akterin; Torbjörn Persson; Laura Mateos; Anna Sandebring; Javier Avila-Cariño; Angel Gutierrez-Rodriguez; Erik Sundström; Arne Holmgren; Bengt Winblad; Angel Cedazo-Minguez
Journal:  EMBO Mol Med       Date:  2012-08-30       Impact factor: 12.137

8.  Oxidative stress affects processing of amyloid precursor protein in vascular endothelial cells.

Authors:  Abebe Muche; Thomas Arendt; Reinhard Schliebs
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

Review 9.  Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms.

Authors:  Kristina Endres; Thomas Deller
Journal:  Front Mol Neurosci       Date:  2017-03-17       Impact factor: 5.639

10.  ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.

Authors:  Florent Letronne; Geoffroy Laumet; Anne-Marie Ayral; Julien Chapuis; Florie Demiautte; Mathias Laga; Michel E Vandenberghe; Nicolas Malmanche; Florence Leroux; Fanny Eysert; Yoann Sottejeau; Linda Chami; Amandine Flaig; Charlotte Bauer; Pierre Dourlen; Marie Lesaffre; Charlotte Delay; Ludovic Huot; Julie Dumont; Elisabeth Werkmeister; Franck Lafont; Tiago Mendes; Franck Hansmannel; Bart Dermaut; Benoit Deprez; Anne-Sophie Hérard; Marc Dhenain; Nicolas Souedet; Florence Pasquier; David Tulasne; Claudine Berr; Jean-Jacques Hauw; Yves Lemoine; Philippe Amouyel; David Mann; Rebecca Déprez; Frédéric Checler; David Hot; Thierry Delzescaux; Kris Gevaert; Jean-Charles Lambert
Journal:  EBioMedicine       Date:  2016-06-02       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.